Andere Sprachen Dermapharm Holding SE

Aktien

A2GS5D

DE000A2GS5D8

DMP

Pharmazeutika

Markt geschlossen - Xetra Andere Börsenplätze 17:35:19 11.06.2026			Nachbörslich 17:52:48
47,95 ^EUR	+3,01 %		47,95	0,00 %

27.05.	Jefferies hebt Ziel für Dermapharm auf 44 Euro - 'Hold'	DP
14.05.	Trumps China-Test und die Märkte auf Rekordniveau

Andere Sprachen

15.05.	DERMAPHARM : Q1 2026 TRANSCRIPT TELEPHONE CONFERENCE
15.05.	Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
13.05.	Dermapharm Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2026
13.05.	Dermapharm confirme ses objectifs après un bon premier trimestre
13.05.	Dermapharm Holding - Q1 consolidated revenue up 1.1% y/y to EUR 305.8 mln
13.05.	Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance
13.05.	Dermapharm Holding SE Confirms Consolidated Earnings Guidance for the Year 2026
13.05.	DERMAPHARM : Q1 2026 INTERIM STATEMENT
13.05.	DERMAPHARM : Q1 2026 WEBCAST
04.05.	Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
09.04.	DERMAPHARM : FY 2025 TRANSCRIPT TELEPHONE CONFERENCE
09.04.	DERMAPHARM : FY 2025 TRANSKRIPT TELEFONKONFERENZ
31.03.	Dermapharm Holding SE announces Annual dividend, payable on July 01, 2026
31.03.	Alstom prend de la vitesse, Inventiva en mauvaise forme
31.03.	DERMAPHARM : FY 2025 ANNUAL REPORT
31.03.	Dermapharm : Webcast fy 2025
31.03.	Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin
31.03.	Dermapharm Holding SE Provides Consolidated Earnings Guidance for the Year 2026
31.03.	Dermapharm : reports dip in revenue, rise in adjusted consolidated EBITDA and margin
30.03.	Dermapharm Holding SE Reports Earnings Results for the Full Year Ended December 31, 2025
27.03.	Dermapharm repurchases 4,299,190 shares
26.03.	Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
10.03.	Dermapharm Launches Share Buyback Offer
10.03.	Dermapharm dans le vert avec l'amélioration de l'Ebitda annuel
10.03.	Dermapharm Holding SE resolves public share buyback offer for up to 4,300,000 shares